Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2026 65.98%
August 31, 2026 65.98%
July 31, 2026 65.98%
June 30, 2026 65.98%
May 31, 2026 65.98%
April 30, 2026 65.98%
March 31, 2026 65.98%
February 28, 2026 65.98%
January 31, 2026 65.98%
December 31, 2025 65.98%
November 30, 2025 65.98%
October 31, 2025 65.98%
September 30, 2025 65.98%
August 31, 2025 65.98%
July 31, 2025 65.98%
June 30, 2025 65.98%
May 31, 2025 65.98%
April 30, 2025 65.98%
March 31, 2025 53.11%
February 28, 2025 43.74%
January 31, 2025 43.74%
December 31, 2024 43.74%
November 30, 2024 93.00%
October 31, 2024 93.00%
September 30, 2024 93.00%
Date Value
August 31, 2024 93.00%
July 31, 2024 93.00%
June 30, 2024 93.00%
May 31, 2024 93.00%
April 30, 2024 93.00%
March 31, 2024 93.00%
February 29, 2024 93.00%
January 31, 2024 93.00%
December 31, 2023 93.00%
November 30, 2023 93.00%
October 31, 2023 93.00%
September 30, 2023 93.00%
August 31, 2023 93.00%
July 31, 2023 93.00%
June 30, 2023 93.00%
May 31, 2023 93.00%
April 30, 2023 93.00%
March 31, 2023 93.00%
February 28, 2023 93.00%
January 31, 2023 93.00%
December 31, 2022 93.00%
November 30, 2022 93.00%
October 31, 2022 93.00%
September 30, 2022 93.00%
August 31, 2022 93.00%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
3-D Matrix Ltd. 88.50%
Healios KK 95.42%
AnGes, Inc. 98.36%
ACADIA Pharmaceuticals, Inc. 77.18%
Alkermes Plc 68.08%

Max Drawdown (5Y) Related Metrics